The Food and Drug Administration on Monday approved Pfizer COVID-19 boosters for 12- to 15-year-olds as schools reopen after the holiday break amid the omicron variant surge.
In a release, the FDA also said it has amended the emergency use authorization for the Pfizer vaccine for the coronavirus to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third dose for certain immunocompromised children 5 through 11 years of age.
https://abcnews.go.com/Health/fda-author...d=82051567
In a release, the FDA also said it has amended the emergency use authorization for the Pfizer vaccine for the coronavirus to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third dose for certain immunocompromised children 5 through 11 years of age.
https://abcnews.go.com/Health/fda-author...d=82051567